Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast in Perennial Allergic Rhinitis
NCT00092118Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Oct 2003
- Primary completion
- May 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of montelukast in perennial allergic rhinitis (PAR), sponsored by Organon & Co.. Started Oct 2003; status: completed.
02
Drugs
montelukast
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT00092118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00092118.